Why have the MitraClip procedure done in China?

China offers the MitraClip procedure at a significantly lower cost—approximately $36,000—compared to $150,000 or more in the U.S. or Europe. Leading Chinese cardiac centers use the same FDA-approved devices and employ high-volume interventional cardiologists with extensive experience in transcatheter valve repair. Patients also benefit from modern hospital facilities and coordinated care packages that include pre-procedure assessment, the procedure itself, and post-discharge follow-up.